Neolignans from North American Magnolia species with cyclooxygenase 2 inhibitory activity

Inflammopharmacology

Volumn 17, Issue 2, 2009, Pages 106-110

  Schuhly W ^a,c   Khan, S I ^b   Fischer, N H ^b,c  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Anti inflammatory; Cyclooxygenase 2; Magnolia; Neolignans

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GALGRAVIN; HONOKIOL; LIPOPOLYSACCHARIDE; MAGNOLIA EXTRACT; MAGNOLOL; NEOLIGNAN; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG ISOLATION; DRUG MECHANISM; ENZYME INHIBITION; FIBROBLAST; MACROPHAGE; MOUSE; NONHUMAN; PLANT LEAF; PLANT SEED; PRIORITY JOURNAL;

ANIMALS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; FIBROBLASTS; LIGNANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MAGNOLIA; MICE; MOLECULAR STRUCTURE; NORTH AMERICA; PLANT EXTRACTS; PLANT LEAVES; SEEDS; VERO CELLS;

EID: 64049090581     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-009-7013-y     Document Type: Article

References (28)

1. Bharate, S. B., Khan, S. I., Tekwani, B. L., Jacob, M., Khan, I. A. and Singh, P. I. (2008). S-Euglobals: Biomimetic synthesis, antileishmanial, antimalarial and antimicrobial activities. Bioorg Med Chem 16, 1328-36.
2. Borenfreund, E., Babich, H. and Martin-Alguacil, N. (1990). Rapid chemosensitivity assay with human normal and tumor cells in vitro. In Vitro Cellular & Developmental Biology 26, 103-4.
3. Deng, S., Cheng, Y., Zhou, J., Tan, N. and Ding, Z. (2001). Magnoquinone and neolignans from Magnolia rostrata. Yunnan Zhiwu Yanjiu 23, 121-5.
4. Dirsch, V. M. and Vollmar, A. M. (2001). Ajoene, a natural product with non-steroidal anti-inflammatory drug (NSAID)-like properties? Biochemical Pharmacology 61, 587-93.
5. Du Bois, R. N., Abramson, S. B., Crofford, L. and Gupta, R. A. (1998). Cyclooxygenase in Biology and Disease. FASEB Journal, 12, 1063-73.
6. El-Feraly, F. S. and Li, W. S. (1978). Phenolic constituents of Magnolia grandiflora L. seeds. Lloydia 41, 442-9.
7. Feltenstein, M. W., Schühly, W., Warnick, J. E., Fischer, N. H. and Sufka, K. J. (2004). Anti-Inflammatory and anti-hyperalogesic effects of sesquiterpene lactones from Magnolia and Bear's Foot. Pharmacology Biochemistry and Behavior 79, 299-302.
8. Fitzpatrick, F. A. (2004). Cyclooxygenase enzymes: regulation and function. Current Pharmaceutical Design 10, 577-88.
9. Griswold, D. E. and Adams, J. L. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. (1996). Medicinal Research Rewiews 16, 181-206.
10. Hsu, M.-F., Lu, M.-C., Tsao, L.-T., Kuan, Y.-H., Chen, C.-C. and Wang, J.-P. (2004). Mechanisms of the influence of magnolol on eicosanoid metabolism in neutrophils. Biochemical Pharmacology 67, 831-40.
11. Hwang, D., Fischer, N. H., Jang, B. C., Tak, H., Kim, J. K. and Lee, W. (1996). Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases. Biochemical & Biophysical Research Communications 226, 810-8.
12. Kijjoa, A., Pinto, M. M. M., Tantisewie, B. and Herz, W. (1989). A biphenyl type neolignan and a biphenyl ether from Magnolia henryi. Phytochemistry 28, 1284-6.
13. Liou, K. T., Shen, Y. C., Chen, C. F., Tsao, C. M. and Tsai, S. K. (2003). The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. European Journal of Pharmacology 475, 19-27.
14. Lopez, H., Valera, A. and Trujillio, J. (1995). Lignans from Ocotea foetens. Journal of Natural Products 58, 782-5.
15. Ma, G., Khan, S. I., Benavides, G., Schühly, W., Fischer, N. H., Khan, I. A. and Pasco, D. (2007). Inhibition of NF-kB mediated transcription and induction of apoptosis by melampolides and repandolides. Cancer Chemotherapy and Pharmacology 60, 35-43.
16. Mardini, I. A. and Fitzgerald, G. A. (2001). Selective inhibitors of cyclooxygenase-2: a growing class of anti-inflammatory drugs. Molecular Interventions 1, 30-8.
17. Maruyama, Y., Ikarashi, Y. and Kurihara, H. Bioactivity and pharmacological aspects of Magnolia. In: Sarker, S. D. and Maruyama, Y. (editors). Magnolia. Medicinal and aromatic plants - industrial profiles, vol. 28. London, New York: Taylor & Francis. (2002). 75-88.
18. Muhammad, I., Takamatsu, S., Mustafal, J., Khan, S. I., Khan, I. A. and Samoylenko, V. (2008). Cox-2 inhibitory activity of cafestol and analogs from coffee beans. Natutral Product Communications 3, 11-16.
19. Mustafa, J., Khan, S. I., Ma, G., Walker, L. A. and Khan, I. A. (2004). Synthesis and anticancer activities of fatty acid analogs of podophyllotoxin. Lipids 39, 167-72.
20. Nitao, J. K., Nair, M. G., Thorogood, D. L., Johnson, K. S. and Scriber, J.M. (1991). Bioactive neolignans from the leaves of Magnolia virginiana. Phytochemistry 30, 2193-5.
21. Park, E. J., Zhao, Y. Z., Na, M., Bae, K., Kim, Y. H., Lee, B. H. and Sohn, D. H. (2003). Protective effects of honokiol and magnolol on tertiary butyl hydroperoxide- or D-galactosamine-induced toxicity in rat primary hepatocytes. Planta Medica 69, 33-7.
22. Park, J., Lee, J., Jung, E., Park, Y., Kim, K., Park, B., Jung, K., Park, E. Kim, J. and Park, D. (2004). In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. European Journal of Pharmacology 496, 189-95.
23. Schühly, W., Khan, I. and Fischer, N. H., (2001). The ethnomedicinal uses of Magnoliaceae from the southeastern United States as leads in drug discovery. Pharmaceutical Biology 39, 63-9.
24. Song, Q. and Fischer, N. H. (1999). Biologically active lignans and neolignans from Magnolia species. Revista de la Sociedad Química de Mexico 43, 211-18.
25. Song, Q., Gomez-Barrios, M. L., Fronczek, F. R., Vargas, D., Thien, L. B. and Fischer, N. H. (1998). Sesquiterpenes from Southern Magnolia virginiana. Phytochemistry 47, 221-6.
26. Sy, L. K. and Brown, G. D. (1998). Biomimetic synthesis of Illicium oligomeric neolignans. Journal of Chemical Research-Synopses 8, 476-7.
27. Toriizuka, K. Traditional medicine and Magnolia. In: Sarker, S. D. and Maruyama, Y. (editors). Magnolia. Medicinal and aromatic plants - industrial profiles, vol. 28. London, New York: Taylor & Francis. (2002). 8-22.
28. Wang, J. P., Hsu, M. F., Raung, S. L., Chen, C. C., Kuo, J. S. and Teng, C. M. (1992). Anti-inflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Archives of Pharmacology 346, 707-12.